SEC Form D · filed October 28, 2016
CURE PHARMACEUTICAL Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Ed Maliski · Oxnard, CADirectorVic Branstetter · Oxnard, CADirectorMark Udell · Oxnard, CAExecIan Sephton · Oxnard, CADirectorRob Davidson · Oxnard, CAExec · DirectorWayne Nasby · Oxnard, CADirectorLuke Ledbetter · New York, NYDirectorAlex Maffeo · New York, NYDirectorCarle D. Stenmark · San Francisco, CADirectorAndrew Lerner · New York, NYExec · DirectorPatrick Hutchines · Luxembourg, LuxembourgExecVic Branstetter · Oxnard, CADirectorBob Glosson · Durham, NCExec · DirectorBarry Boniface · Durham, NCDirectorJerry Nowlin · Durham, NCDirectorMark Feidler · Durham, NCDirectorJack Barry · Durham, NCExecJohn L. King, Jr · Fort Worth, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗